Breast cancer detection tool from Parascript wins FDA nod

09/6/2013 | American City Business Journals

The FDA has granted Parascript approval for its AccuDetect software, designed to aid in early breast cancer diagnosis. In an analysis, the technology helped improve the detection of tumors missed in initial exams by 18.8% and achieved a 14.2% reduction in the number of follow-up tests from false positives, the company said.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA